These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 19170121)
1. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121 [TBL] [Abstract][Full Text] [Related]
2. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Zhang ML; Lu S; Zhou L; Zheng SS Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503 [TBL] [Abstract][Full Text] [Related]
3. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584 [TBL] [Abstract][Full Text] [Related]
4. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors. Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672 [TBL] [Abstract][Full Text] [Related]
5. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells. Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834 [TBL] [Abstract][Full Text] [Related]
7. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells. Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714 [TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767 [TBL] [Abstract][Full Text] [Related]
9. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
10. Menin molecular interactions: insights into normal functions and tumorigenesis. Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329 [TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049 [TBL] [Abstract][Full Text] [Related]
12. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas. Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer. Zhang ML; Lu S; Zheng SS Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889 [TBL] [Abstract][Full Text] [Related]
14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077 [TBL] [Abstract][Full Text] [Related]
15. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients. Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation. Dreijerink KM; Höppener JW; Timmers HM; Lips CJ Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155 [TBL] [Abstract][Full Text] [Related]
17. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
18. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours. Lindberg D; Akerström G; Westin G Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708 [TBL] [Abstract][Full Text] [Related]